Edition:
United Kingdom

People: DKSH Holding AG (DKSH.S)

DKSH.S on Swiss Exchange

51.40CHF
23 Jul 2019
Change (% chg)

CHF0.95 (+1.88%)
Prev Close
CHF50.45
Open
CHF50.55
Day's High
CHF52.55
Day's Low
CHF50.35
Volume
184,127
Avg. Vol
138,238
52-wk High
CHF76.10
52-wk Low
CHF48.90

Tanner, Hans 

Dr. Hans Christoph (Chris) Tanner, Ph.D., has been Non-Executive Independent Director of DKSH Holding Ltd. since 2011. He chairs the Audit Committee. He is currently Head of Transactions and Member of the Board of Cosmo Pharmaceuticals NV, Dublin and CFO of Cassiopea SpA, Lainate. Since March 2017, he is member of the Wyss Zurich Evaluation Board. Furthermore, since May 2017, Dr. Tanner is member of the supervisory board of Paion AG, Aachen. From 2006 until May 2016, he was the CFO of Cosmo Pharmaceuticals SA, Luxembourg. From 1998 to 2002, he was with A&A Investment Management, and co-founder and member of the Board of 20 Min Holding and 20 Minuten Schweiz AG. Prior to this, he worked for UBS AG for 21 years, initially as a corporate banker in Zurich, Madrid and Los Angeles and then headed UBS AG’s corporate finance and capital markets activities in Zurich from 1992 to 1998. He is a member of the Board of Directors of CureVac AG, Tuebingen, Joimax GmbH, Karlsruhe, Qvanteq AG, Zurich, and FARa Holz AG. He holds a degree in economics (lic. oec. HSG) and a doctorate in economics from the University of St. Gallen, Switzerland.

Basic Compensation

Total Annual Compensation, CHF 225,000
Restricted Stock Award, CHF --
Long-Term Incentive Plans, CHF --
All Other, CHF 11,000
Fiscal Year Total, CHF 236,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --